HomeVideoIMI 2 Info Day Indicative Call Topics

IMI 2 Info Day Indicative Call Topics

RADAR Remote assessment of disease and relapse Theo Meert, Senior Director External Innovations NS, Janssen Research & Development, J&J. Assessing risk and progression of pre-diabetes and type 2 diabetes to enable disease modification
Bernd Stowasser, Head of European Public Partnerships, Sanofi-Aventis. Towards a quantitative biological approach for neuropsychiatry. Overview – EFPIA Representative Hugh Marsten, Head of In Vivo Pharmacology, Eli Lilly. Questions & Answers Moderated by Elisabetta Vaudano, Scientific Pillar Coordinator, IMI.


Previous post
IMI 2 Info Day Workshop A
Next post
Dr Almanza: "Gastric Sleeve probable cure for Diabetes Type 2"

Leave a Reply

Be the First to Comment!

Notify of